ImmuCell Share Price
NASDAQ: ICCC | HealthcareImmuCell Stock Performance
ImmuCell Share Price Chart
ImmuCell Quarterly Profit & Loss
All figures in USD
ImmuCell Annual Profit & Loss
All figures in USD
ImmuCell Balance Sheet
All figures in USD Million
ImmuCell Cash Flow
All figures in USD Million
About ImmuCell
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
ImmuCell Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $10.41 | $11.43 | +13.68% |
Oct 2026 | $9.63 | $10.05 | -0.40% |
Sep 2026 | $9.89 | $10.09 | +2.49% |
Aug 2026 | $11.06 | $9.85 | -11.55% |
Jul 2026 | $10.48 | $11.13 | +10.42% |
Jun 2026 | $9.71 | $10.08 | -0.40% |
May 2026 | $8.61 | $10.12 | +22.37% |
Apr 2026 | $6.37 | $8.27 | +30.75% |
Mar 2026 | $6.29 | $6.33 | -4.53% |
Feb 2026 | $6.12 | $6.63 | +7.20% |
Jan 2026 | $6.14 | $6.18 | +0.00% |
Dec 2025 | $4.76 | $6.18 | +26.90% |